Clinical Trial Update: Mitoxantrone Hydrochloride Liposome Combined With BU/Cy Were Used as a Conditioning Regimen for Patients With Intermediate/Adverse Risk or Persistently Positive MRD AML [NA]

View source ↗

Summary

A ClinicalTrials.gov entry describes using mitoxantrone hydrochloride liposome with busulfan and cyclophosphamide as a conditioning regimen for AML patients wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• BUSULFAN (Busulfan)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Mitoxantrone hydrochloride liposome (Mitoxantrone hydrochloride liposome)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: AML | NA | Status: NOT_YET_RECRUITING